PATENT CLAIM ANALYSIS

Application Number: 16079868
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "04400A"]

Abstract:
Aberrantly expressed piRNAs, genetically associated piRNAs and their relationship with cancer risk and severity are provided. Compositions and methods of using piRNA for treating cancer are provided. Methods of diagnosing subjects and determining the efficacy of active agents for treating cancer are also provided. Methods of correlating variant piRNA to cancer are also disclosed.

Claim (Index 23):
A method of treating a subject for a breast cancer comprising administering the subject an effective amount of wildtype piR_016975, piR_019169, piR_018292, piR_017178, piR_019368, piR_019911, piR_000560, piR_001207, piR_012753, piR_003728, piR_001078, and piR_012925 or a close variant thereof with the same or similar activity to wildtype, or a stimulator of expression thereof, to increase the expression of the piRNA in the cells of the subject.

Metadata:
- Claim Count in Document: 6.0
- Percentile: 96.0
- Lexical Diversity: 1.63889
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13470233', '15313555', '14112296', '14020811', '15422725']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7379643217220804
- 35 USC 102 Novelty (BERT): 0.5016484543383178
- Combined Prediction Score: 0.7143327349837042
- Mean Citation Score: 233.341736
- Max Citation Score: 247.30536
- Similarity Product: 173.60242770362382

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test